Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches
Liqing Jiang, Weifeng Huang, Mulan Cao, Yingsong Jiang, Simin Li, Mengling Li, Rui Yang, Zhongjun Wu, Yan Wang, Cheng Lv, Zuotian Huang · 2024
Read Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches by Liqing Jiang, Weifeng Huang, Mulan Cao, Yingsong Jiang, Simin Li, Mengling Li, Rui Yang, Zhongjun Wu, Yan Wang, Cheng Lv, Zuotian Huang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11531474.txt.
Description
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. This study investigates the role and mechanisms of ADAM9 as a biomarker and potential therapeutic target in HCC. Utilizing RNA-sequencing data and clinicopathological characteristics from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, we conducted survival and meta-analyses, functional enrichment, and immune infiltration studies.
Catalog record
| CREATOR | Liqing Jiang, Weifeng Huang, Mulan Cao, Yingsong Jiang, Simin Li, Mengling Li, Rui Yang, Zhongjun Wu, Yan Wang, Cheng Lv, Zuotian Huang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |